This BCC Research report discusses market growth, size and opportunities with respect to applications, geographic region and technologies. Forecast trends and revenue are given through 2019. Major players, applications and technologies, trends and market dynamics, competitive intelligence and geographic trends are also analyzed in the report.
Use this report to: - Receive market analysis of the global SNP genotyping segments and subsegments by geographic regions, applications and technologies. - Identify market trends, issues and factors impacting SNP genotyping market. - Track alliances, joint ventures, mergers and acquisitions, new product developments, and research and development. - Learn about the recent developments and the product portfolios of the major players.
Highlights - The global single nucleotide polymorphism (SNP) genotyping market was valued at $3.5 billion in 2013. This market is expected to reach $4.3 billion in 2014 and $11.5 billion in 2019, compound annual growth rate (CAGR) of 21.9% from 2014 to 2019. - The North American market is expected to increase from $1.8 billion in 2014 to $4.9 billion by 2019, at a CAGR of 21.8% from 2014 to 2019. - The Asia-Pacific region is expected to grow the fastest from 2014 to 2019 with a CAGR of 24.1%, with revenue of $767.9 million in 2014 and about $2.3 billion in 2019.
Introduction & Scope
INTRODUCTION The Global SNP Genotyping report discusses market growth, size and opportunities with respect to applications, geographic region and technologies. The report includes forecast trends and revenue through 2019. Major players, applications and technologies, trends and market dynamics, competitive intelligence and geographic trends are well researched and analyzed in the report.
STUDY GOALS AND OBJECTIVES - Define and discuss the global SNP genotyping market. - Analyze market structure, segments and subsegments. - Estimate market revenues of the global SNP genotyping segments and subsegments by geographic regions, applications and technologies. - Identify market trends, issues and factors impacting SNP genotyping market. - Study various submarkets with respect to growth drivers and inhibitors of the SNP genotyping market. - Explain opportunities in the SNP genotyping market with respect to geographies and applications. - Profile major players and analyze their core competencies and strategies in the SNP genotyping market. - Track alliances, joint ventures, mergers and acquisitions, new product developments, and research and development in the global SNP genotyping market.
TITLE DESCRIPTION SNP genotyping is a study of genetic differences in single nucleotide polymorphisms (SNPs) in cells and humans. It is the most widely used technique to discern variations in the DNA sequence. DNA bases (A, T, C and G) comprise the 3-billion letter string of the human genome. The sequence of this string is almost always same for everyone. Research has found that sometimes a single letter in the sequence may vary from one human to the other. SNP genotyping is the name given to the study of these DNA variations between humans, and this practice has gained importance in medical diagnostics and research. SNPs are the fundamental markers in several human ailments and are therefore keenly studied in pharmacogenomics to better customize personalized medicine.
Researchers are confronted with the task of sorting out SNPs that correlate with specific influences on patients. Reliable findings will mean that such SNPs will function as predictive markers for several dimensions of medical treatment, such as efficacy of and responsiveness to drugs. Such a pharmacogenetic methodology economizes on time, money and distress for tens of thousands of patients by enabling precise diagnoses and appropriate medication.
SNPs assume great importance in view of their role in the identification of a person’s ancestry, susceptibility to disease, responsiveness to drugs, side effects experienced and even how he or she looks or acts. SNPs are the most significant group of genetic changes that impact common diseases. Some studies suggest that nine out of the top 10 leading fatal diseases have a similar genetic makeup and actually one or more SNP controls the propensity to develop a particular disease.
SCOPE OF THE REPORT This research report incorporates an in-depth analysis of the SNP genotyping market, including market estimations and trends through 2019. Major players, competitive intelligence, technologies, applications, market dynamics and geographic opportunities are discussed in detail in the report. The report discusses recent developments and the product portfolios of the major players. Patent analysis in the report focuses on providing technological trends across the last few years in regions such as the U.S., Europe and Japan. The report presents market analysis and estimates CAGR (compound annual growth rate) for SNP genotyping technologies and geographies.
Our reports have been used by over 10K customers, including:
168 pages •
By Global Industry Analysts
• Apr 2021
- Global Spatial Genomics and Transcriptomics Market to Reach $275.8 Million by 2027
- Amid the COVID-19 crisis, the global market for Spatial Genomics and Transcriptomics estimated at US$170.7 Million in the year 2020, is projected to reach a revised size of US$275.8 Million by 2027, growing at a CAGR of...
178 pages •
By Global Industry Analysts
• Apr 2021
- Global RNA Analysis/Transcriptomics Market to Reach $8.7 Billion by 2027
- Amid the COVID-19 crisis, the global market for RNA Analysis/Transcriptomics estimated at US$3.7 Billion in the year 2020, is projected to reach a revised size of US$8.7 Billion by 2027, growing at a CAGR of 13.1% over the analysis...
Global Single-Cell Multi-Omics Market to Reach $3,188.9 Million by 2025 Market Report Coverage - Single-Cell Multi-Omics Market Segmentation • Product Type – Consumables, Instruments, and Software • Sample Type – Human Samples, Animal Samples, and Microbial Samples • Omics Type –...
Spatial Genomics & Transcriptomics Market Report Overview Spatial Genomics & Transcriptomics market size outlook report provides comprehensive coverage of market landscape including strategic growth areas, unique insights, and major trends across Spatial Genomics & Transcriptomics market types and applications. It is a focused study on...
The global spatial genomics and transcriptomics market is projected to reach USD 404 million by 2025 from USD 178 million in 2020, at a CAGR of 17.8% during the forecast period. Market growth is largely driven by the increasing adoption of spatial genomics and transcriptomics analysis among small companies and startups, expanding applications...
Global Spatial Genomics and Transcriptomics Market to Reach $2,173.0 Million by 2030 Market Report Coverage - Spatial Genomics and Transcriptomics Market Segmentation • Product Type – Kits and Assays, Instruments, Software, and Services • Sample Type – Fresh Frozen Tissues, Fixed Frozen...
Transcriptomics Market Report Overview Transcriptomics market size outlook report provides comprehensive coverage of market landscape including strategic growth areas, unique insights, and major trends across Transcriptomics market types and applications. It is a focused study on Transcriptomics market space including global and regional...
23andMe, Inc - Tech Innovator Profile
23andMe, Inc. (23andMe) is a personal genomics and biotechnology company that leverages machine learning (ML) technology to provide DNA analysis services.
The report provides information and insights into 23andMe, Inc.’s, including...
This study covers the world outlook for ribonucleic acid (RNA) analysis and transcriptomics across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in question (in millions of U.S. dollars), the percent share the country is of the region, and...
187 pages •
By Global Industry Analysts
• Oct 2019
Transcriptomics market worldwide is projected to grow by US$6 Billion, driven by a compounded growth of 13.9%. Microarray, one of the segments analyzed and sized in this study, displays the potential to grow at over 12.1%. The shifting dynamics supporting this growth makes it critical for businesses in this space to keep abreast of the changing...
Genomics Proteomics And Enabling Technology
You can change your Cookie Settings at any time but parts of our site will not function correctly without them.